Choice Medical Transcription is categorized under Health Services in Pittsfield, NH and active since 2010.
Choice Medical Transcription was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Jocelyn Beauregard at the company’s single location by writing to 55 Old Colony Road, Pittsfield, New Hampshire NH 03263 or by phoning (603) 435-0011. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Choice Medical Transcription |
| Contact Person: | Jocelyn Beauregard |
| Address: | 55 Old Colony Road, Pittsfield, New Hampshire 03263 |
| Phone Number: | (603) 435-0011 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Choice Medical Transcription was started in 2010 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jocelyn Beauregard for inquiries that concern Choice Medical Transcription by calling the company number (603) 435-0011, as your correspondence is most welcome. Additionally, the physical location of the single location of Choice Medical Transcription can be found at the coordinates 43.330825,-71.357798 as well as the street address 55 Old Colony Road in Pittsfield, New Hampshire 03263.
For its online presence, you may visit Choice Medical Transcription’s website at and engage with its social media outlets through on Twitter and on Facebook.